Developing Original Droplet-based Digital PCR Assays to Detect Circulating Biomarkers
Valérie Taly, CNRS Research Director, Group Leader and Professor, Université Paris Cité
Technological innovations such as droplet-based digital PCR has been instrumental in the recent developments that we have seen in the use of liquid biopsy for patient follow-up. Development of new assays and their application within large clinical studies will be presented. Applications to both cancer and covid 19 patient follow up will be exemplified.
|
|